Not applicableStudy completedNCT01427660What this trial is testingIDecide.Decido: Diabetes Medication Decision Support StudyWho this might be right forDiabetes, Type 2 University of Michigan 190
Not applicableStudy completedNCT01281605What this trial is testingComparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 DiabetesWho this might be right forType 2 Diabetes Mackay Memorial Hospital 181
Post-approval studies (Phase 4)Study completedNCT00641407What this trial is testingBedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 DiabetesWho this might be right forType 2 Diabetes MellitusHypoglycemia University of Campania Luigi Vanvitelli 100
Not applicableStudy completedNCT04738591What this trial is testingMHealth Intervention to Support Diabetes Medication Adherence (Pilot Study)Who this might be right forDiabetes Mellitus, Type 2 Fundació d'investigació Sanitària de les Illes Balears 207
Not applicableStudy completedNCT00254124What this trial is testingUse of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.Who this might be right forType 2 Diabetes MellitusObesity University of Calgary 130
Large-scale testing (Phase 3)Looking for participantsNCT07527078What this trial is testingEvaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes (T2DM) Gan & Lee Pharmaceuticals. 350
Large-scale testing (Phase 3)Study completedNCT00736099What this trial is testingSafety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 2,122
Not applicableStudy completedNCT05319548What this trial is testingPlant Pigments for Human Health: Impact of Lycopene and Anthocyanins on Bioefficacy of Provitamin A Carotenoids From CarrotsWho this might be right forHealthy University of Wisconsin, Madison 12
Large-scale testing (Phase 3)Study completedNCT03175120What this trial is testingA Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)Who this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 453
Testing effectiveness (Phase 2)Study completedNCT00382239What this trial is testingAssess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus AstraZeneca 153
Not applicableUnknownNCT05817097What this trial is testingEffect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA DatabaseWho this might be right forCerebral InfarctionInfarction, BrainDipeptidyl-Peptidase IV Inhibitors Ajou University School of Medicine 22,119
Early research (Phase 1)Study completedNCT05089617What this trial is testingTo Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese SbjectsWho this might be right forDiabetes Mellitus Youngene Therapeutics Inc., Ltd. 31
Post-approval studies (Phase 4)Looking for participantsNCT07244003What this trial is testingEfficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlWho this might be right forT2DM (Type 2 Diabetes Mellitus) Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430
Not applicableUnknownNCT05591391What this trial is testingThe Efficacy of Mallya in Type 2 Diabetes Transiting From Oral Antidiabetic Drugs to iGlarLixiWho this might be right forMallya Taipei Veterans General Hospital, Taiwan 40
Large-scale testing (Phase 3)Study completedNCT05413369What this trial is testingIGlarLixi vs IDegAsp in Chinese Participants After OAD(s)Who this might be right forType 2 Diabetes Mellitus Sanofi 582
Post-approval studies (Phase 4)Looking for participantsNCT07254572What this trial is testingAnti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetesWho this might be right forCoronary Artery DiseasePreDiabetes National Institute of Cardiology, Warsaw, Poland 300
Large-scale testing (Phase 3)Study completedNCT03078478What this trial is testingA Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic DrugsWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 1,609
Large-scale testing (Phase 3)Study completedNCT00765817What this trial is testingAddition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes AstraZeneca 261
Large-scale testing (Phase 3)Study completedNCT01045447What this trial is testingComparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 465
Post-approval studies (Phase 4)Study completedNCT01378117What this trial is testingDipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesWho this might be right forType 2 Diabetes MellitusHospitalizationHyperglycemia Emory University 90